Kwang Woo Ahn, PhD

Professor

Locations

Biostatistics

Contact Information

Education

PhD, The University of Iowa, Iowa City, IA, 2008
MS, The University of Iowa, Iowa City, IA, 2005
BS, Korea University, Seoul, Republic of Korea, 2003

Research Areas of Interest

Biostatistics
Clinical Trial
Controlled Clinical Trial
Data Accuracy
Data Interpretation, Statistical
High Dimensional Data Analysis
Historical Data for Clinical Trials
Machine Learning
Missing Data
Right-Censored Data Analysis

Research Experience

Survival and competing risks data analysis, high dimensional data analysis, missing data, bioinformatics, personalized medicine

Research Interests

Dr. Kwang Woo Ahn is a professor in the division of biostatistics at the Medical College of Wisconsin. He joined the division in the fall of 2008. He has been collaborating with various research groups at MCW including Center for International Blood & Marrow Transplant Research (CIBMTR), Department of Physiology, and Department of Plastic Surgery. In CIBMTR, he is serving as PhD statistician of several working committees including Chronic Leukemia, Lymphoma, and Pediatric Cancer. He is involved in projects on hypertension, next generation sequencing data from Physiology. His current research interest includes survival analysis and variable selection.

Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma.

(Furqan F, Ahn KW, Chen Y, Kaur M, Abutalib SA, Ahmed N, Ahmed S, Kharfan-Dabaja MA, Friedberg J, Gregory T, Hill L, Sterling C, Barta SK, Shadman M, Perales MA, Zain J, Herrera AF, Sauter C, Hamadani M.) Br J Haematol. 2023 Jan;200(1):54-63 PMID: 36120837 PMCID: PMC9772096 SCOPUS ID: 2-s2.0-85138249429 09/20/2022
KIR-favorable TCR-αβ/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trial.

(Pulsipher MA, Ahn KW, Bunin NJ, Lalefar N, Anderson E, Flower A, Cairo MS, Talano JA, Chaudhury S, Kitko CL, Duke JL, Monos D, Leung W, Dvorak CC, Abdel-Azim H.) Blood. 2022 Dec 15;140(24):2556-2572 PMID: 35776909 PMCID: PMC9918850 SCOPUS ID: 2-s2.0-85144585749 07/02/2022
Marginal semiparametric transformation models for clustered multivariate competing risks data.

(He Y, Kim S, Mao L, Ahn KW.) Stat Med. 2022 Nov 20;41(26):5349-5364 PMID: 36117139 PMCID: PMC9650627 SCOPUS ID: 2-s2.0-85138223278 09/19/2022
The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Patient-Reported Outcome Data from the RDSafe and BMT CTN 0201 Clinical Trials.

(Farhadfar N, Ahn KW, Bo-Subait S, Logan B, Stefanski HE, Hsu JW, Panch S, Confer D, Liu H, Badawy SM, Beitinjaneh A, Diaz MA, Hildebrandt GC, Kelkar AH, Lazarus HM, Murthy HS, Preussler JM, Schears RM, Sharma A, van der Poel M, Bruce JG, Pulsipher MA, Shaw BE, Wingard JR, Switzer GE.) Transplant Cell Ther. 2022 Sep;28(9):603.e1-603.e7 PMID: 35688325 PMCID: PMC9427696 SCOPUS ID: 2-s2.0-85134804662 06/11/2022
Outcomes of Autologous Hematopoietic Cell Transplantation in Older Patients with Diffuse Large B-Cell Lymphoma.

(Munshi PN, Chen Y, Ahn KW, Awan FT, Cashen A, Shouse G, Shadman M, Shaughnessy P, Zurko J, Locke FL, Goodman AM, Bisneto JCV, Sauter C, Kharfan-Dabaja MA, Meyers G, Jaglowski S, Herrera A, Hamadani M.) Transplant Cell Ther. 2022 Aug;28(8):487.e1-487.e7 PMID: 35609865 PMCID: PMC9375438 SCOPUS ID: 2-s2.0-85132887608 05/25/2022
Noninfectious Pulmonary Toxicity after Allogeneic Hematopoietic Cell Transplantation.

(Patel SS, Ahn KW, Khanal M, Bupp C, Allbee-Johnson M, Majhail NS, Hamilton BK, Rotz SJ, Hashem H, Beitinjaneh A, Lazarus HM, Krem MM, Prestidge T, Bhatt NS, Sharma A, Gadalla SM, Murthy HS, Broglie L, Nishihori T, Freytes CO, Hildebrandt GC, Gergis U, Seo S, Wirk B, Pasquini MC, Savani BN, Sorror ML, Stadtmauer EA, Chhabra S.) Transplant Cell Ther. 2022 Jun;28(6):310-320 PMID: 35314376 PMCID: PMC9197865 SCOPUS ID: 2-s2.0-85129519446 03/23/2022
Predicting asymptomatic severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection rates of inpatients: A time-series analysis - CORRIGENDUM.

(Rivera F, Ahn KW, Munoz-Price LS.) Infect Control Hosp Epidemiol. 2022 May 25:1 PMID: 35611855 05/26/2022
Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation?

(Abou-Ismail MY, Fraser R, Allbee-Johnson M, Metheny L 3rd, Ravi G, Ahn KW, Bhatt NS, Lazarus HM, de Lima M, El Jurdy N, Hematti P, Beitinjaneh AM, Nishihori T, Badawy SM, Sharma A, Pasquini MC, Savani BN, Sorror ML, Stadtmauer EA, Chhabra S.) Br J Haematol. 2022 May;197(3):326-338 PMID: 35286719 PMCID: PMC9675037 SCOPUS ID: 2-s2.0-85126235994 03/15/2022
Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit.

(Mei M, Hamadani M, Ahn KW, Chen Y, Kharfan-Dabaja MA, Sauter C, Herrera AF.) Haematologica. 2022 May 01;107(5):1214-1217 PMID: 35112554 PMCID: PMC9052914 SCOPUS ID: 2-s2.0-85129629839 02/04/2022
Impact of conditioning regimen intensity on the outcomes of peripheral T-cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T-cell lymphoma patients undergoing allogeneic transplant.

(Savani M, Ahn KW, Chen Y, Ahmed S, Cashen AF, Shadman M, Modi D, Khimani F, Cutler CS, Zain J, Brammer JE, Rezvani AR, Fenske TS, Sauter CS, Kharfan-Dabaja MA, Herrera AF, Hamadani M.) Br J Haematol. 2022 Apr;197(2):212-222 PMID: 35106754 PMCID: PMC9018546 SCOPUS ID: 2-s2.0-85124009986 02/03/2022
Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research.

(Murthy HS, Ahn KW, Estrada-Merly N, Alkhateeb HB, Bal S, Kharfan-Dabaja MA, Dholaria B, Foss F, Gowda L, Jagadeesh D, Sauter C, Abid MB, Aljurf M, Awan FT, Bacher U, Badawy SM, Battiwalla M, Bredeson C, Cerny J, Chhabra S, Deol A, Diaz MA, Farhadfar N, Freytes C, Gajewski J, Gandhi MJ, Ganguly S, Grunwald MR, Halter J, Hashmi S, Hildebrandt GC, Inamoto Y, Jimenez-Jimenez AM, Kalaycio M, Kamble R, Krem MM, Lazarus HM, Lazaryan A, Maakaron J, Munshi PN, Munker R, Nazha A, Nishihori T, Oluwole OO, Ortí G, Pan DC, Patel SS, Pawarode A, Rizzieri D, Saba NS, Savani B, Seo S, Ustun C, van der Poel M, Verdonck LF, Wagner JL, Wirk B, Oran B, Nakamura R, Scott B, Saber W.) Transplant Cell Ther. 2022 Apr;28(4):187.e1-187.e10 PMID: 35081472 PMCID: PMC8977261 SCOPUS ID: 2-s2.0-85125344790 01/27/2022
Competing risks regression models with covariates-adjusted censoring weight under the generalized case-cohort design.

(Xu Y, Kim S, Zhang MJ, Couper D, Ahn KW.) Lifetime Data Anal. 2022 Apr;28(2):241-262 PMID: 35034255 PMCID: PMC8977245 SCOPUS ID: 2-s2.0-85123103100 01/17/2022